Oncology Venture bjuder in till Pressträff 8 april kl. 16.30

NEXT STORY
Cue Biopharma to Present Immuno-STAT Platform Technology at PEGs Boston 2019
PREV STORY
Translate Bio Appoints Richard Wooster as Chief Scientific Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect to Present at 2017 World Antimicrobial Resistance Congress

YONKERS, N.Y., Sept. 11, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

author_avatar
NASDAQ Market News

Daxor Corporation Selected for U.S. Army Contract to Develop a Blood Volume Analyzer for Improvement of Combat Casualty Care

NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an ...

author_avatar
NASDAQ Market News

Immutep Enters Into Clinical Trial Collaboration and Supply Agreement With MSD

SYDNEY, Australia, March 11, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or ...

author_avatar
NASDAQ Market News